✦ LIBER ✦

CT and PET: Early Prognostic Indicators of Response to Imatinib Mesylate in Patients with Gastrointestinal Stromal Tumor

✍ Scribed by Holdsworth, Clay H.; Badawi, Ramsey D.; Manola, Judith B.; Kijewski, Marie F.; Israel, David A.; Demetri, George D.; Van den Abbeele, Annick D.

Book ID: 120188105
Publisher: American Roentgen Ray Society
Year: 2007
Tongue: English
Weight: 783 KB
Volume: 189
Category: Article
ISSN: 0361-803X
DOI: 10.2214/AJR.07.2496

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathologic, radiologic and PET scan resp

Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate

✍ B.K.P. Goh; P.K.H. Chow; K.L. Chuah; W.M. Yap; W.K. Wong 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

The value of PET, CT and in-line PET/CT

The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate

✍ G. W. Goerres; R. Stupp; G. Barghouth; T. F. Hany; B. Pestalozzi; E. Dizendorf; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 384 KB

FDG-PET to Measure Response to Targeted

FDG-PET to Measure Response to Targeted Therapy: The Example of Gastrointestinal Stromal Tumor and Imatinib Mesylate (Gleevec)

✍ Van den Abbeele, Annick D.; Ertuk, Mehmet 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 356 KB

Focal progression in patients with gastr

Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients

✍ Salah-Eddin Al-Batran; Joerg Thomas Hartmann; Florian Heidel; Jan Stoehlmacher; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 326 KB

Phase II study of motesanib in Japanese

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate

✍ Akira Sawaki; Yasuhide Yamada; Yoshito Komatsu; Tatsuo Kanda; Toshihiko Doi; Mas 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 302 KB

Use of positron emission tomography in o

Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs)

✍ Annick D. Van den Abbeele; Ramsey D. Badawi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 869 KB